摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-Benzyl-3-methoxy-2-propionylamino-propionamide | 444342-63-6

中文名称
——
中文别名
——
英文名称
N-Benzyl-3-methoxy-2-propionylamino-propionamide
英文别名
N-benzyl-3-methoxy-2-(propanoylamino)propanamide
N-Benzyl-3-methoxy-2-propionylamino-propionamide化学式
CAS
444342-63-6
化学式
C14H20N2O3
mdl
——
分子量
264.324
InChiKey
IUPMANYFQVBFSR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.7
  • 重原子数:
    19
  • 可旋转键数:
    7
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    67.4
  • 氢给体数:
    2
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    丙酰氯N-苄基-2-氨基-3-甲氧基丙酰胺 在 TEA 作用下, 以 四氢呋喃 为溶剂, 反应 0.17h, 以71%的产率得到N-Benzyl-3-methoxy-2-propionylamino-propionamide
    参考文献:
    名称:
    Quantitative Structure−Activity Relationship Analysis of Functionalized Amino Acid Anticonvulsant Agents Using k Nearest Neighbor and Simulated Annealing PLS Methods
    摘要:
    We report the development of rigorously validated quantitative structure-activity relationship models for 48 chemically diverse functionalized amino acids with anticonvulsant activity. Two variable selection approaches, simulated annealing partial least squares (SAPLS) and k nearest neighbor (kNN), were employed. Both methods utilize multiple descriptors such as molecular connectivity indices or atom pair descriptors, which are derived from two-dimensional molecular topology. QSAR models with high internal accuracy were generated, with leave-one-out cross-validated R(2)(q(2)), values ranging between 0.6 and 0.8. The q(2) values for the actual dataset were significantly higher than those obtained for the same dataset with randomly shuffled. activity values, indicating that models were statistically significant. The original dataset was further divided into several training and test sets, with highly predictive models providing q(2) values greater than 0.5 for the training sets and R(2) values greater than 2 values greater than 0.5 for the training se 0.6. for the test sets. These models were capable of predicting with reasonable accuracy the activity of 13 novel compounds not included in the original dataset. The successful development of highly predictive QSAR models affords further design and discovery of novel anticonvulsant agents.
    DOI:
    10.1021/jm010488u
点击查看最新优质反应信息

文献信息

  • Lacosamide detection assay
    申请人:UCB Pharma GmbH
    公开号:EP2378291A1
    公开(公告)日:2011-10-19
    The present application relates to a method of determining the anticonvulsant drug lacosamide in a body fluid sample, particularly in plasma, serum or saliva using a HPLC-UV method, and a lacosamide analogue as a standard. The present application also relates to a new method of determining the lacosamide content in a mammals body by measuring the lacosamide concentration or amount in the saliva.
    本申请涉及一种用高效液相色谱-紫外法测定体液样品,特别是血浆、血清或唾液中抗惊厥药物拉科酰胺含量的方法,并以拉科酰胺类似物为标准。本申请还涉及一种通过测量唾液中的拉科酰胺浓度或含量来确定哺乳动物体内拉科酰胺含量的新方法。
  • [EN] LACOSAMIDE DETECTION ASSAY<br/>[FR] TEST DE DÉTECTION DU LACOSAMIDE
    申请人:UCB PHARMA GMBH
    公开号:WO2011128079A2
    公开(公告)日:2011-10-20
    The present application relates to a method of determining the anticonvulsant drug lacosamide in a body fluid sample, particularly in plasma, serum or saliva using a HPLC-UV method, and a lacosamide analogue as a standard. The present application also relates to a new method of determining the lacosamide content in a mammals body by measuring the lacosamide concentration or amount in the saliva.
  • [EN] PROCESS FOR PREPARATION OF 2-ACETAMIDO-N-BENZYL-3-METHOXYPROPIONAMIDE<br/>[FR] PROCÉDÉ DE PRÉPARATION DE 2-ACÉTAMIDO-N-BENZYL-3-MÉTHOXYPROPIONAMIDE
    申请人:GLENMARK GENERICS LTD
    公开号:WO2013072933A2
    公开(公告)日:2013-05-23
    The present invention relates to a process for preparation and purification of 2-acetamido-N-benzyl-3-methoxypropionamide or enantiomer thereof.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸